News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InterGenetics Incorporated Release: First Genetic-Based Breast Cancer Risk Test Enters International Market



3/1/2007 12:46:32 PM

OKLAHOMA CITY--(BUSINESS WIRE)--InterGenetics, a predictive medicine company, focused on molecular diagnostics and targeted therapy for cancer, announced the international release of the first genetic-based, breast cancer risk test that incorporates both personal history and gene-based information to determine a woman’s future breast cancer risk. Opaldia, a genetic health service provider with a network of clinics, will release OncoVue® in the United Kingdom and Ireland under an exclusive agreement.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES